About 407 results
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
Asciminib safer and more effective than TKIs for CML patients
Asciminib Shows Superior Efficacy vs Standard-of-Care Front ...
Nature - Discovery of a novel BTK inhibitor S-016 and ...
CML: Asciminib First Line wirksamer als Standard ...
Suspending enzalutamide does not impact QOL in ...
Sequential drug treatment targeting cell cycle and cell fate ...
BCR: Inflación de mayo podría llegar al cero - El Men
South African Journal of Oncology